Skip to main content
Contact Us
Subscribe
E-Edition
59°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Gritstone bio
Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update
November 11, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTSQ
Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
September 30, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 13, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 09, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite
April 01, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
March 05, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 08, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine
October 11, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million
September 27, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 09, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 11, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
March 09, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.